USA Financial Formulas’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-1,575
Closed -$486K – 457
2025
Q3
$486K Sell
1,575
-1,230
-44% -$385K 0.09% 91
2025
Q2
$881K Sell
2,805
-1,478
-35% -$427K 0.15% 65
2025
Q1
$1.12M Sell
4,283
-442
-9% -$120K 0.19% 44
2024
Q4
$1.23M Buy
+4,725
New +$1.19M 0.19% 34
2023
Q3
– Sell
-34
Closed -$9.8K – 538
2023
Q2
$9.8K Buy
+34
New +$10.3K 0.02% 201
2020
Q2
– Sell
-3,490
Closed -$578K – 310
2020
Q1
$578K Buy
3,490
+2,649
+315% +$484K 0.37% 77
2019
Q4
$144K Buy
+841
New +$140K 0.06% 148

Other funds holding PODD

USA Financial Formulas's PODD Position: Q4 2025 in Review

USA Financial Formulas sold out of Insulet (PODD) in Q4 2025, closing a stake of 1,575 shares — an estimated $486K sold.

USA Financial Formulas first reported a position in PODD in Q4 2019 and held it in 7 quarters. The position peaked at $1.23M in Q4 2024. 834 funds tracked by Wall St. Rank hold PODD as of Q4 2025.

  • USA Financial Formulas reported no remaining Insulet position as of Q4 2025 after selling out during the quarter.
  • USA Financial Formulas sold 1,575 Insulet shares in Q4 2025, an estimated $486K.
  • USA Financial Formulas first reported a position in Insulet in Q4 2019 and held it in 7 quarters.
  • USA Financial Formulas's Insulet position peaked at $1.23M in Q4 2024.
  • 834 funds tracked by Wall St. Rank held Insulet as of Q4 2025.

Based on USA Financial Formulas's 13F filing for Q4 2025, filed 14 Jan 2026.